ATLASTheriva Biologics (TOVX) earnings date: Nov 11, 2026
Theriva Biologics (TOVX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TOVX
| Last price | $0.16 (-3.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.9% |
| Earnings beat history | Beat the EPS estimate in 0 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Theriva Biologics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Theriva Biologics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Theriva Biologics. You can switch it off at any time.
Alert me before TOVX reportsFree to start. Creating an account takes under a minute.
Notify me when Theriva Biologics reports
Track TOVX free Add Theriva Biologics to a free ATLAS watchlist and see its next report date in one place.
TOVX earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 4 reports) | 0 of 4 (0%) |
| Average EPS surprise | -21.1% |
| Average move around a report | ±1.8% (last 4) |
| Sector | Healthcare · Biotechnology |
Theriva Biologics earnings history: last 4 reports
Theriva Biologics last reported on Aug 11, 2026: EPS of -$0.07 against an estimate of -$0.05 (-40.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.05 | -$0.07 | -40.0% | Miss | +4.4% |
| Jun 2, 2026 | $0.23 | $0.17 | -26.1% | Miss | +2.1% |
| May 5, 2026 | -$0.05 | -$0.05 | 0.0% | In line | +0.5% |
| Nov 12, 2025 | -$0.38 | -$0.45 | -18.4% | Miss | -0.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TOVX
See the fair value, the probability range and the earnings history of Theriva Biologics on its ATLAS page.
Theriva Biologics (TOVX) stock analysisPlans from €3.99 a month.
Theriva Biologics earnings: frequently asked questions
When does Theriva Biologics (TOVX) report earnings?
Theriva Biologics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does TOVX beat earnings estimates?
Of its last 4 reports with a recorded result, Theriva Biologics beat the EPS estimate 0 times; the average surprise was -21.1%. Past results do not predict the next one.
How much does TOVX move around earnings?
Over its last 4 reports the stock moved an average of 1.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Theriva Biologics beat earnings estimates last quarter?
Theriva Biologics last reported on Aug 11, 2026: EPS of -$0.07 against an estimate of -$0.05 (-40.0% surprise), a miss.
How much does TOVX usually move in a day?
On a normal trading day the ATLAS model puts TOVX’s one-day range at about ±3.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer